派格生物医药（杭州）股份有限公司（股票代码：02565）于2026年5月6日发布了截至2026年4月30日的月度证券变动报告。报告显示，公司本月未进行新增发行、购回、注销或库藏股变动，股本结构保持稳定。
根据公告，普通股H股的已发行股数月末结存为284,300,339股，与上月相同。非上市股份（其他类普通股）数量则维持在106,791,193股，未发生变化。注册股本合计为人民币391,091,532元，与上月保持一致。
公告同时明确，公司未发生股权激励、可转债及其他涉及股份的协议或安排等相关变动。截至4月底，H股公众持股比例符合港交所上市规则要求。
公告由联席公司秘书黄一峰签署。公司表示，将继续严格遵守香港联合交易所有限公司上市规则及相关法律法规的各项要求。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.